Pfm Health Sciences, LP Uni Qure N.V. Transaction History

Pfm Health Sciences, LP

$1.05 Billion
Q2 2025

A detailed history of Pfm Health Sciences, LP transactions in Uni Qure N.V. stock. As of the latest transaction made, Pfm Health Sciences, LP holds 174,331 shares of QURE stock, worth $2.49 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

174,331

Previous 599,967 70.94%

Holding current value

$2.49 Million

Previous $6.36 Million 61.79%

% of portfolio

0.23%

Previous 0.51%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$8.34 - $17.27 $3.55 Million - $7.35 Million	-425,636 Reduced 70.94%	174,331 $2.43 Million
Q1 2025 May 15, 2025	BUY	$10.6 - $18.08 $3.36 Million - $5.73 Million	316,809 Added 111.88%	599,967 $6.36 Million
Q4 2024 Feb 14, 2025	BUY	$4.54 - $17.73 $733,346 - $2.86 Million	161,530 Added 132.81%	283,158 $5 Million
Q3 2024 Nov 14, 2024	SELL	$3.78 - $10.12 $578,007 - $1.55 Million	-152,912 Reduced 55.7%	121,628 $599,000
Q1 2024 May 14, 2024	BUY	$4.82 - $6.93 $1.32 Million - $1.9 Million	274,540 New	274,540 $1.43 Million
Q2 2023 Aug 14, 2023	SELL	$11.12 - $22.2 $22.8 Million - $45.5 Million	-2,049,453 Reduced 97.13%	60,617 $694,000
Q1 2023 May 15, 2023	SELL	$18.7 - $23.07 $3.59 Million - $4.44 Million	-192,244 Reduced 8.35%	2,110,070 $42.5 Million
Q4 2022 Feb 14, 2023	SELL	$18.12 - $27.32 $1.65 Million - $2.49 Million	-90,997 Reduced 3.8%	2,302,314 $52.2 Million
Q3 2022 Nov 14, 2022	BUY	$16.98 - $25.54 $2.66 Million - $4.01 Million	156,941 Added 7.02%	2,393,311 $44.9 Million
Q2 2022 Aug 15, 2022	BUY	$13.15 - $20.45 $22.4 Million - $34.8 Million	1,701,746 Added 318.31%	2,236,370 $41.7 Million
Q1 2022 May 16, 2022	BUY	$14.54 - $21.5 $7.77 Million - $11.5 Million	534,624 New	534,624 $9.66 Million
Q4 2019 Feb 14, 2020	SELL	$37.13 - $74.62 $43 Million - $86.5 Million	-1,158,694 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $38.7 Million - $75.6 Million	983,940 Added 563.04%	1,158,694 $45.6 Million
Q2 2019 Aug 14, 2019	SELL	$52.76 - $82.19 $12.8 Million - $19.9 Million	-242,108 Reduced 58.08%	174,754 $13.7 Million
Q1 2019 May 15, 2019	BUY	$27.39 - $68.41 $11.4 Million - $28.5 Million	416,862 New	416,862 $24.9 Million

Others Institutions Holding QURE

# of Institutions

184

Shares Held

51.7M

Call Options Held

4.43M

Put Options Held

1.27M

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $668M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.

Account

Pfm Health Sciences, LP Uni Qure N.V. Transaction History